Skip to content

Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes

Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00819975
Enrollment
12
Registered
2009-01-09
Start date
Unknown
Completion date
2008-05-31
Last updated
2009-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial Lipemia, Type 2 Diabetes

Keywords

Casein, Whey, postprandial, Triglyceride, Free fatty acids, Retinyl palmitate, Incretins, Type 2 Diabetes

Brief summary

Enhanced and prolonged postprandial triglyceride responses involve increased cardiovascular risk in type 2 diabetes. It has been demonstrated that dietary fat and carbohydrates profoundly influence postprandial hypertriglyceridemia in type 2 diabetes, whereas little information exists about the effect of proteins. The purpose of this study is to compare the effects of the milk proteins casein, Whey Isolate, Whey Hydrolysate, and Alphalact-Albumin on postprandial lipid and incretin responses to a high-fat meal in type 2 diabetes.

Interventions

DIETARY_SUPPLEMENTCasein
DIETARY_SUPPLEMENTWhey Isolate
DIETARY_SUPPLEMENTWhey Hydrolysate
DIETARY_SUPPLEMENTAlphalact-Albumin

Sponsors

The Danish Obesity Research Centre
CollaboratorOTHER
Nordic Centre of Excellence
CollaboratorOTHER
Arla Foods
CollaboratorINDUSTRY
Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 Diabetes

Exclusion criteria

* Liver-, Kidney- and/or Heart Disease * Serious Hypertension (160/110 mmHg)

Design outcomes

Primary

MeasureTime frame
Triglyceride levels0h- 2h- 4h- 6h- 7h- 8h postprandial

Secondary

MeasureTime frame
Incretin levels0h- 0.5h- 1h- 2h- 4h- 6h- 8h postprandial

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026